It has been shown that the functional architecture of the default mode network (DMN) can be affected by serotonergic challenges and these effects may provide insights on the neurobiological bases of depressive symptomatology. To deepen our understanding of this possible interplay, we used a double-blind, randomized, cross-over design, with a control condition and two interventions to decrease (tryptophan depletion) and increase (tryptophan loading) brain serotonin synthesis. Resting-state fMRI from 85 healthy subjects was acquired for all conditions 3 hr after the ingestion of an amino acid mixture containing different amounts of tryptophan, the dietary precursor of serotonin. The DMN was derived for each participant and session. Permutation testing was performed to detect connectivity changes within the DMN as well as between the DMN and other brain regions elicited by the interventions. We found that tryptophan loading increased tryptophan plasma levels and decreased DMN connectivity with visual cortices and several brain regions involved in emotion and affect regulation (i.e., putamen, subcallosal cortex, thalamus, and frontal cortex). Tryptophan depletion significantly reduced tryptophan levels but did not affect brain connectivity. Subjective ratings of mood, anxiety, sleepiness, and impulsive choice were not strongly affected by any intervention. Our data indicate that connectivity between the DMN and emotion-related brain regions might be modulated by changes in the serotonergic system. These results suggest that functional changes in the brain associated with different brain serotonin levels may be relevant to understand the neural bases of depressive symptoms.
| INTRODUCTION
The brain's default mode network (DMN) has emerged as a landmark in cognitive and affective neuroscience since its first description in 2001 (Raichle et al., 2001) . It is now generally accepted that the synchronized activity between its regions might play a critical role for integrating representational information across the cortex (Margulies et al., 2016) . Recently, it has been shown that pharmacological challenges may impact the functional architecture of the DMN, especially in regions with elevated receptor density for particular neurotransmitters (e.g., cingulate cortex; Klaassens et al. [2015] ).
Specifically, DMN regions receive dense serotonin (5-hydroxytryptamine ) innervations (Saulin, Savli, & Lanzenberger, 2012) . Serotonergic ascending fibers from the dorsal raphe nucleus project onto the lateral cerebral cortex and the hypothalamus, the basal forebrain, and the amygdala. Further projections from the latter regions continue to the cingulate cortex, the medial cerebral cortex and the hippocampus (Hornung, 2003) , which are parts of the DMN (Buckner, Andrews-Hanna, & Schacter, 2008) . Presumably as a result of this innervation, changes in the functional coherence of the DMN following serotonergic medication were observed, especially in brain regions involved in mood and attention regulation (Klaassens et al., 2016 (Klaassens et al., , 2015 Posner et al., 2013; Van de Ven, Wingen, Kuypers, Ramaekers, & Formisano, 2013) .
Among serotonergic interventions, acute tryptophan challenges are well-established techniques to manipulate the synthesis of 5-HT in the central nervous system in a transitory and marginally invasive manner.
Although direct measures of tryptophan influx into the human brain are currently not possible, the effectiveness of these challenges has been demonstrated by several animal studies (Biskup et al., 2012; Grimes, Cameron, & Fernstrom, 2000; Lieben, Blokland, Westerink, & Deutz,, 2004 ) and indirect measures of 5-HT levels in humans (e.g., CSF; Williams, Shoaf, Hommer, Rawlings, & Linnoila, 1999; Young & Gauthier, 1981) . These interventions reduce or enhance the availability of the essential amino acid tryptophan, the dietary precursor of 5-HT in the brain, and thus help to investigate the role of the serotonergic system in the modulation of cognitive functions and mood among others (Lindseth, Helland, & Caspers, 2015; Silber & Schmitt, 2010) .
Although simplistic and refined through the years, the hypothesis of a dysfunction in the serotonergic system as a primary factor in the etiology of affective disorders (Cowen & Browning, 2015) has promoted the use of tryptophan challenges in the study of depressive symptomatology (Lindseth et al., 2015) . In addition, an aberrant DMN connectivity was found in depressed individuals, establishing a neural model that helps to explain the states of excessive rumination, that is, DMN hyperconnectivity, and deficits in goal-directed behavior, that is, hypoconnectivity between DMN and cognitive control systems, that characterize this disorder (Kaiser, Andrews-Hanna, Wager, & Pizzagalli, 2015) . Consequently, DMN changes following tryptophan manipulations might provide relevant clues regarding the origin of depressive symptomatology.
Existing studies investigating the effects of tryptophan depletion on DMN connectivity describe reduced functional connectivity of the precuneus and enhanced functional connectivity of the frontal cortex in healthy Kunisato et al., 2011) and psychiatric populations. In contrast, tryptophan loading, a less-used intervention, led to greater connectivity between frontal DMN regions and the lateral PFC (Kroes et al., 2014) . However, the use of relatively small samples and a single tryptophan condition limits the conclusions that can be drawn from these investigations.
While the effects on 5-HT synthesis obtained after tryptophan challenges seem to be rapid (Biskup et al., 2012; Dingerkus et al., 2012) , animal models have shown that low or single doses of SSRIs increase 5-HT concentrations to a level that floods somatodendritic 5-HT 1A autoreceptors, which in turn may cause a subsequent 5-HT depletion-like state with its corresponding behavioral manifestations (Cools, Roberts, & Robbins, 2008) instead of an expected increase in 5-HT levels. This mechanism of action might explain why DMN changes in healthy subjects after single doses of SSRIs mirror those obtained after tryptophan depletion in posterior parts of the DMN Klaassens et al., 2015; Kunisato et al., 2011; Van de Ven et al., 2013) . On the other hand, the action of serotonergic manipulations on frontal DMN regions seems to be less clear, showing both increases and decreases in connectivity after either SSRIs (Klaassens et al., 2015 (Klaassens et al., , 2016 or tryptophan manipulations Kunisato et al., 2011) . Hence, further investigations are still necessary in order to understand how different brain 5-HT levels affect the functional coherence of the DMN.
The aim of our study was to investigate the effects of serotonergic manipulations on the functional architecture of the DMN in healthy subjects following two tryptophan interventions, namely: acute tryptophan depletion (ATD) and acute tryptophan loading (ATL).
Both interventions were tested against a balanced condition (BAL), which provided the recommended daily intake of tryptophan for adults (see Experimental procedure). To observe how different brain 5-HT levels may affect the DMN connectivity, we also investigated possible linear relationships between both interventions (ATD-ATL).
Based on previous findings and the existing literature, we hypothesized that ATD would decrease the functional connectivity of posterior parts of the DMN (i.e., precuneus and PCC) but increase the connectivity of frontal and medial parts of the DMN (i.e., vmPFC, retrosplenial cortex, and angular gyrus) whereas ATL would have opposite effects. The methodology used in this study also allowed us to investigate connectivity changes between the DMN and other brain regions following each tryptophan manipulation (i.e., voxel-tonetwork connectivity). Additionally, we used similar behavioral measures as previous studies that reported more impulsive choices as well as higher anxiety and depression levels after ATD, and increasing sleepiness after ATL (Dougherty, Richard, James, & Mathias, 2010; Lindseth et al., 2015; Silber & Schmitt, 2010 ). Finally, we investigated possible associations between functional connectivity changes and these behavioral measures.
| MATERIALS AND METHODS

| Participants
One hundred and twelve healthy participants completed the three sessions of the study. Of these, we discarded five participants who received accidentally the same mixture in all sessions, four participants with excessive movement during the resting-state scan (see section on "Image preprocessing"), four participants with structural brain anomalies (e.g., cysts, enlarged ventricles) detected by a neuroradiologist, two participants who did not complete one resting state scan and 12 participants with limited brain coverage or scanner artifacts in one or all resting-state sessions. Therefore, data from 85 participants (41 females; M age = 32.68 years, SD age AE 5.81, range = 21-42) were analyzed in this study. These participants form part of the sample already reported by Neukam et al. (2018) . The detailed recruitment process is described in the Supporting Information Material S1.
Participants gave written informed consent and received monetary compensation for their participation. The study protocol was approved by the local ethics committee of the Technische Universität Dresden and was in accordance with national legislation and the Declaration of Helsinki.
| Experimental procedure
Participants took part in three sessions and received one of the following drinks: acute tryptophan depletion (ATD), balanced (BAL), or acute tryptophan loading (ATL) in a randomized, double-blind, placebo-controlled (BAL), crossover study, with at least 1 week between sessions (elapsed days between sessions: M = 23, SD = 25). The dose of amino acids in the mixtures was adjusted to participant's body weight (Dingerkus et al., 2012; Moja et al., 1988) and contained the same amount of large neutral amino acids (LNAA) but differed in the amount of tryptophan. In the ATD condition, tryptophan was completely absent, the BAL condition contained 7 mg/kg body weight (equivalent to the recommended daily allowance for adults; Richard et al., 2009) 
| Biochemical measures
A venous catheter (Braunüle Universität Dresden as described in Henle, Walter, Krause, and Klostermeyer (1991) . Complete blood samples from 71 participants were available for analysis.
The ratio of tryptophan to the sum of the other LNAA (TRP/ P LNAA) in the peripheral blood at each time point was calculated as the best estimate of the intervention effects in each session (Dingerkus et al., 2012) . For statistical analyses, the area under the curve (AUC) was computed using the four time points. Before calculating the AUC, all four time points were normalized by subtracting the values of T0 from all time points, thereby accounting for interindividual differences in baseline blood levels. These AUC scores were entered into a repeated-measures ANOVA.
| Behavioral assessment
Statistical analyses were conducted using SPSS for Windows (release Scale (KSS; Akerstedt & Gillberg, 1990 ) and a 9-item Visual Analogue Scale (VAS: heightened, excited, balanced, depressed, lethargic, activated, sad, relaxed, stressed [In-house assessment, ZI, Mannheim, Germany] ). These questionnaires were applied in the order mentioned above at the four time points of the session. Additionally, we assessed impulsive choice using three tasks of the Value-Based DecisionMaking battery (see Pooseh, Bernhardt, Guevara, Huys, & Smolka, 2017 for a complete description). Briefly, risk aversion for gains and risk seeking for losses were assessed using probability discounting for gains and losses, respectively. In these tasks, participants needed to choose between a sure amount that they could win or lose and the probability of winning/losing a larger amount of money (e.g., 75%
probability of winning €5 or winning €2 for sure, or a 50% probability of losing €8 or losing €3 for sure). The resulting main discounting parameters from these tasks (k) were log-transformed in order to approximate them to a normal distribution. Finally, loss aversion was assessed with a mixed gambles task. In this task, participants received a credit of €10 at the beginning of the game and then needed to decide whether to accept or reject an offer with a 50/50 chance of either gaining one amount of money or losing another amount (e.g., refusing to gamble or accepting a gamble that offered either winning €15 or losing €8). These three tasks were administered at a single time point after the fMRI session. Due to missing data the number of complete behavioral datasets ranged from 82 to 85. Other behavioral and cognitive measures as well as demographic information were acquired (see Neukam et al. (2018) and Supporting Information Material S3). The study design including the number of participants in each session and condition and a schematic overview of one study session are depicted in Figure 1 .
In order to test intervention effects (ATD and ATL vs. BAL) and effects between interventions (ATD vs. ATL) on the three behavioral ratings, we subtracted the scores obtained at baseline (T0) from the scores obtained before the scan session (T2) and performed a repeated-measures ANOVA with the resulting scores. Results were Bonferroni-corrected for 14 comparisons. If the F-test indicated significant differences, post-hoc paired t-tests were performed to determine directionality of the effects.
| MR data acquisition
All fMRI sessions were carried out 3 hr after the ingestion of the mixtures because previous research (Dingerkus et al., 2012) and our pilot tests showed after this time, the lowest and highest tryptophan peaks in ATD and ATL, respectively. The resting-state fMRI sequence was performed after a decision-making task and a short break. fMRI data were collected on a 3 Tesla whole-body MRI Scanner Magnetom Trio Tim (Siemens Healthcare GmbH, Erlangen, Germany) equipped with a 32 channel head coil using a single-shot gradient echo-planar imaging on a black crosshair presented on the center of a white screen. An eye-tracking camera was used to monitor the participants and to ensure that they remained awake during the whole resting-state session. 
| Image preprocessing
| Generation and analysis of the default mode network
We used a template-based approach, which has been validated by previous studies (Klaassens et al., 2015 (Klaassens et al., , 2016 and reliably provides spatial maps of established large-scale brain networks. Briefly, we used the 10 templates from to derived the networks identified in more than 1,600 studies. These templates included: high, medial and lateral visual networks, default-mode network, cerebellar network, sensorimotor network, auditory network, cingulo-opercular network, right and left fronto-parietal networks (see Supporting Information Figure S2 ; . To obtain an individual representation of each network, we used a dual regression analysis (Beckmann, Mackay, Nicola, & Smith, 2009 ). Here the templates were linearly regressed against the functional data of each subject, resulting in individual time courses (spatial regression) for each one of the 10 networks. These time courses were normalized and then regressed against the corresponding functional datasets (temporal regression) to estimate 10 subject-specific voxel-tonetwork spatial maps for each subject and pharmacological condition.
Additional individual mean time courses from white matter, cerebrospinal fluid and the six subject-specific motion parameters were added
Study design. Part a shows the study design with the cross-over randomization of the tryptophan interventions (ATD, acute tryptophan depletion; BAL, balanced; ATL, acute tryptophan loading), the final number of participants for each intervention and session (N = 85) and the number of participants in each possible order of interventions. Part B shows the timeline of a study session. The mixture was prepared 1 hr before the participant arrived. At T0, the first blood sample was taken as a baseline measure of tryptophan plasma concentrations, followed by the ingestion of the mixture and mood and behavioral assessments. Additional blood samples were taken 1, 3, and 6 hr after the ingestion of the mixture. The fMRI session was carried out 3 hr after the drink [Color figure can be viewed at wileyonlinelibrary.com] during the last stage of the dual regression to remove sources of spurious variance and residual motion (see Supporting Information Material S4). As a multivariate approach, this dual regression procedure allowed the estimation of a "clean" representation of the DMN in which temporal and spatial signals that this network shares with other networks, were removed. In the dual regression approach, the estimated maps do not depend on the initial subject-specific major Eigenspaces (PCA) and therefore, may lie outside the network's boundaries ). The voxel-wise regression coefficients contained in the resulting spatial maps represent the synchronization between BOLD temporal dynamics at a given voxel and the mean BOLD time courses of a specific network. The strength of the voxel-to-network connectivity is given by the value of these coefficients (Klaassens et al., 2015 (Klaassens et al., , 2016 . Only the spatial maps representing the DMN were used in the higher-level analysis (85 subjects × 3 interventions = 255 DMN maps).
Due to the unknown distribution of the data, nonparametric testing was used for group-level analyses. To delineate the effects of intervention on the DMN, a repeated-measures ANOVA was performed, with "intervention" (ATD, BAL, and ATL) as a withinsubject factor. We used Faster Permutation Inference as implemen- FWE correction over the six tested contrasts was performed, using the option "corrcon" implemented in PALM (Winkler, Webster, et al., 2016) , which takes into account the dependencies that might exist between contrasts. These comparisons of subject-specific maps indicated which brain areas (within or outside the DMN map)
are stronger connected to the DMN under one condition with respect to the other.
Additionally, we tested potential repetition effects. To this aim, a repeated measures ANOVA with "intervention" (ATD, BAL, and ATL) as a within-subjects factor and "intervention order" (i.e., the six possible order combinations of the interventions; see Figure 1 ) as betweensubject factor, was used. A significant interaction between these two factors would indicate that the observed effects on DMN connectivity are driven by the repetition of the resting-state scan and not solely by a given intervention.
Due to postulated gender differences in brain 5-HT metabolism (Nishizawa et al., 1997), we explored whether gender moderates the effects of the tryptophan interventions. To this end, a third repeated-measures ANOVA was included, with "intervention" as a within-subject factor and "gender" (males, females) as a betweensubject factor. These additional models were also tested using 500 permutations, with a tail approximation as implemented in PALM, yielding voxel-wise maps identified with TFCE and corrected at 0.05.
Finally, we compared the mean FD measures in a repeated measures model to test whether in-scanner motion differed between interventions or sessions.
| Analyses of brain-behavior associations
To determine potential brain-behavior associations, we performed
Pearson correlations between the behavioral scores and the brain regions with significant intervention effects on DMN connectivity.
Specifically, the difference of regional parameter estimates between two interventions (e.g., BAL -ATL) was correlated with their corresponding difference in behavioral scores (e.g., KSS BAL -KSS ATL ).
3 | RESULTS
| Effects of intervention on blood plasma levels of tryptophan and P LNAA
To test the effects of our interventions in the peripheral blood, Table S1 .
Finally, neither gender nor intervention order had any effect on tryptophan plasma measures (all ps > 0.2).
| Effects of intervention on mood, vigilance, and impulsive choice
None of the behavioral scores survived Bonferroni correction for 14 comparisons. For completeness, we reported uncorrected p-values (main effects of intervention and pair-wise comparisons) in Table 1 . Table S2 ).
| Effects of intervention on DMN connectivity
No significant differences in DMN connectivity were found between both interventions (ATD vs. ATL).
Regarding possible confounders or moderators, framewise displacement analyses revealed no differences in-scanner motion between interventions or session (all ps > 0.10). Moreover, no interaction between intervention order and interventions were found, indicating that the repetition of the resting-state scan did not affect DMN connectivity. No significant gender-by-intervention interaction on DMN connectivity could be found, indication that interventions had comparable effects for males and females.
| DISCUSSION
This study is the first to use both, tryptophan depletion and loading, together with a control condition to manipulate brain 5-HT levels and FIGURE 2 Pharmacokinetics of the acute tryptophan intervention: In both graphs, the x axis displays the four time points of blood sampling. On the left graph, the y axis displays the plasma levels of free tryptophan. On the right graph, the ratio of tryptophan to the sum of the other large neutral amino acids (TRP/ P LNAA) is shown. The resting-state scan was carried out after a decision-making task, 3.5 hr after the ingestion of the mixture. The abbreviations are acute tryptophan depletion (ATD), balanced (BAL), and acute tryptophan loading (ATL). The shaded areas indicate bias-corrected and accelerated (BCa) 95% confidence intervals. The graph includes complete data from 71 participants. ** p < 0.0001 [Color figure can be viewed at wileyonlinelibrary.com] None of the comparisons survived Bonferroni correction for 14 tests. Asterisks indicate ps < 0.05, uncorrected for multiple comparisons. N = 82-85. STAI-G X1, state-trait anxiety inventory-state, scale X1; KSS, Karolinska sleepiness scale; VAS, visual analogue scale, mm, millimeters; PDG, probability discounting gains (k on log scale); PDL, probability discounting losses (k on log scale); MG, mixed gambles (lambda).
investigate related changes in DMN functional connectivity in a large cohort of healthy adults. We found that, compared with the control condition (BAL), higher brain 5-HT levels (ATL) decreased the func- In the same way, higher brain 5-HT levels (ATL) reduced the connectivity between the DMN and the thalamus and putamen. These structures form part of the limbic-cortical-striatal-pallidal-thalamic circuits (LCSPT), which are primarily involved in emotional processing, affect regulation and are also implicated in the pathophysiology of mood disorders (Drevets, Price, & Furey, 2008; Greicius et al., 2007) .
Moreover, PET studies have revealed high serotonin synthesis capacity rates in these areas (Okazawa, Leyton, Benkelfat, Mzengeza, & Diksic, 2000; Saulin et al., 2012) , indicating their susceptibility to different 5-HT levels.
The decreased connectivity between the DMN and a cluster located in the subcallosal cortex following ATL deserves special attention. The subcallosal cortex comprises the adjacent ventromedial PFC and Brodmann areas 24 and 25 (Vogt, Nimchinsky, Vogt, & Hof, 1995) and plays a fundamental role in affective valuation of stimuli and expression of negative emotions (Drevets, Savitz, & Trimble, 2008) .
Functional and structural changes in the subcallosal cortex and its adjacent areas are observed in mood and depressive disorders (Drevets, Savitz, et al., 2008) . Furthermore, this area exhibits high densities of 5-HT transporters and 5-HT 1A receptors (Varnas, Halldin, & Hall, 2004) , which may enhance its susceptibility to serotonergic manipulations (Talbot & Cooper, 2006 ). An increased functional connectivity between the DMN and the subgenual prefrontal cortex (sgPFC), the caudal portion of the subcallosal area, is a common finding in depressive disorders (Berman et al., 2011; Greicius et al., 2007) .
In addition, a recent model proposed that this hyperconnectivity may explain depressive rumination by means of a two-system interaction:
the DMN that brings in self-referential processes and the sgPFC that provides emotional loading to these processes (Hamilton, Farmer, Fogelman, & Gotlib, 2015 ).
An elevated connectivity of the DMN is consistently reported in depression (Berman et al., 2011; Greicius et al., 2007; Hamilton et al., 2011; Lois & Wessa, 2016; Sheline et al., 2009; Ye et al., 2015) and individuals at high risk for depression (Posner et al., 2016) manipulations such as antidepressant agents, were found to normalize the elevated DMN connectivity in depressed patients (Posner et al., 2013) and, similar to our findings, decrease the connectivity between DMN regions and subcortical regions in healthy individuals (McCabe & Mishor, 2011) , pointing to a plausible neural substrate of depressive symptoms that can be targeted by medication.
In contrast to the effects of ATL on DMN connectivity and previous studies Helmbold et al., 2016; Kunisato et al., 2011) , depleting tryptophan yielded only small effects that failed to reach statistical significance. Furthermore, these effects were numerically in the same direction as ATL, that is, if anything ATD slightly decreased connectivity to the DMN.
While our blood measures indicated that ATD significantly lowered plasma tryptophan levels, the lack of robust neural effects may arise from differences in 5-HT stores among our participants or the presence of adaptive brain processes (Young, 2007) that might prevent significant decreases of brain 5-HT in our healthy individuals compared with psychiatric populations . Furthermore, methodological differences may also explain why others have reported ATD effects. For example, seed-based approaches provide more power due to strong a priori hypotheses regarding the functional connectivity of the seed region and, therefore, capture more subtle connectivity changes (Eisner et al., 2017 Table 2 ). Horizontal lines on the plots represent means and 95% confidence intervals. *p < 0.05, FWE corrected and adjusted for six comparisons performed [Color figure can be viewed at wileyonlinelibrary.com] of low-frequency fluctuation (ALFF; Kunisato et al., 2011) , that do not quantify functional connectivity (Di et al., 2013) . In addition, we suspect that ATD might have smaller effects than found by previous small studies, which leads to an overestimations of effect sizes (Fanelli, Costas, & Ioannidis, 2017) . In contrast, our study was performed in a larger sample (n = 85), which provided sufficient power (1 − β = 0.80) to detect small-to medium-sized effects at the behavioral and network level (α = 0.05; dz = 0.34) and medium-sized effects at the voxel level (α = 0.001; dz = 0.50) (Faul, Erdfelder, Lang, & Buchner, 2007) , but still ATD effects were not evident. Lastly, we acknowledge that all these interpretations are speculative and certainly merit future in-depth investigation.
At the behavioral level, none of our measures showed significant changes after correction for multiple testing. Regarding the effects of ATD on mood and anxiety, decreases in these scores are mostly reported in depressed or recovered depressed patients, perhaps reflecting a selective vulnerability of the serotonergic system (FusarPoli et al., 2006) . In addition, depressed patients might also exhibit associations between mood scores and functional connectivity strengths (Posner et al., 2013; Wang et al., 2015; Zhu et al., 2012) , in which symptomatic improvements are correlated with reductions in functional connectivity (Wang et al., 2015) . In a similar manner, the effects of ATL on these measures may depend on the initial state of the serotonergic system of the individuals. For example, large doses of tryptophan during the daytime may have calming effects in healthy adults but reduce sleep latency and increase subjective ratings of sleepiness in individuals with sleep disturbances (Hartmann, 1982; Silber & Schmitt, 2010 ). Since we investigated healthy volunteers, it is not surprising that these changes and associations were not statistically reliable in our study. Lastly, although the serotonergic system is involved in the expression of impulsive behaviors (Miyazaki, Miyazaki, & Doya, 2012) , our measures of impulsive choice were neither affected by any intervention nor related to functional connectivity changes. Behavioral analyses of this lab support these observations, showing that impulsive choice is not affected by transient changes of tonic 5-HT, but modulated by individual differences in the serotonergic system . Nevertheless, our results highlight the role of higher 5-HT brain synthesis as a modulator of the connectivity between the DMN and brain regions involved in emotion processing. One might speculate that diminished serotonergic function in these areas leads to a hyperconnectivity with the DMN and therefore, promotes depressogenic cognition, but caution is warranted due to the known neurobiological differences between depressed patients and healthy individuals and the distributed nature of depression (Pandya, Altinay, Malone, & Anand, 2012) .
| Limitations
Our study has some limitations. First, it has been shown that short scan lengths impact the reliability of the resting-state data across sessions (Birn et al., 2013) , which at the same time, reduces the statistical power and allows the detection of only large effect sizes. Future studies might use improved scanning protocols including longer scanning times (e.g., 9-12 min; (Birn et al., 2013) ) and accelerated EPI sequences with much shorter TRs (i.e., multiband) which may yield more stable estimates of connectivity strengths, allowing the detection of smaller effects that were not evident in our study (e.g., ATD).
In addition, study designs with pre-and post-intervention scans would provide a more stable baseline against which the conditions of interest can be compared. Second, the resting state scan was performed after a decision-making task and a short break (about 2 min). Therefore, possible carry-over effects from the previous task cannot be ruled out. To discard these potential confounds, well-tailored studies entirely dedicate to investigate resting-state activity are encouraged.
Finally, despite the extended use of tryptophan challenges for more than 40 years up to now, the specificity of their action on the serotonergic system remains a matter of debate (Crockett et al., 2012; Van Donkelaar et al., 2011) . Therefore, further animal and human research is still needed to draw stronger conclusions about the impact of tryptophan challenges on brain 5-HT levels.
| CONCLUSION
To sum up, our study is the first to use both ATD and ATL, together with a baseline condition in the same subjects to shed light on acute connectivity changes of the DMN following serotonergic manipulations. Our results expand a large body of ongoing research regarding the serotonergic modulation of the DMN Helmbold et al., 2016; Klaassens et al., 2015; Kunisato et al., 2011; Posner et al., 2013; Van de Ven et al., 2013) . More specifically, our data support the notion of decreased connectivity between the DMN and emotion-related regions after increasing brain 5-HT levels and suggest that these functional changes represent a key feature for the understanding of the neural basis of depressive symptomatology.
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